IMUX
IMMUNIC, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.62
+2.61%Sep 11, 2026, 21:27 UTC
Duane Nash resigned as a member of the Board of Directors of Immunic, Inc., effective September 10, 2026.
Source:Sep 2, 2026, 12:54 UTC
Immunic Inc announced it will host a virtual R&D day on September 9, 2026, focused on relapsing multiple sclerosis, ahead of expected topline results from its Phase 3 ENSURE trials by end of 2026.
Source:Aug 11, 2026, 10:30 UTC
Immunic, Inc. reported financial results for the second quarter ended June 30, 2026.